Treatment for CLL

Newly Diagnosed With CLL: What Do You Need to Know?

A panel of CLL experts discuss what newly diagnosed patients should know; from diagnosis and disease monitoring to second opinions and making treatment decisions. Watch now to learn more about living with CLL.

Published:

Ask the CLL Expert Live Replay

Leading CLL expert Dr. Jeff Sharman answered questions from the Patient Power community LIVE. Watch the replay now to hear answers to your questions about treatment, research, managing side effects and more.

Published:

Session Two: What You Should Know About CLL Treatment, Genetic Testing and Research

Watch the replay of session two of our “Understanding CLL: What You Should Know About Treatment, Genetic Testing and Research” town meeting.

Published:

Session One: What You Should Know About CLL Treatment, Genetic Testing and Research

Watch the replay of session one of our “Understanding CLL: What You Should Know About Treatment, Genetic Testing and Research” town meeting.

Published:

Understanding the CLL Treatment Landscape: Getting Educated and Speaking Up

CLL patient advocate Mark Silverstein shares tips for others to become a self-advocate while making treatment decisions and communicate effectively with their healthcare team.

Published:

Can There Be Too Many CLL Treatment Options?

Do more options create more problems? A panel of CLL experts discuss how new avenues in research affect the CLL treatment landscape and the challenge of choosing the most appropriate therapy for each individual patient.

Published:

The Role of Venetoclax in Treating CLL

A Patient Power community member writes in, where does venetoclax fit in with all the other CLL therapies? Watch now to hear CLL expert Dr. Michael Keating explain.

Published:

Mark’s CLL Journey: FCR to Combination Therapies to Transplant

CLL patient and advocate Mark Silverstein shares his experience with several different therapies and the unanticipated challenges he faced on his treatment journey.

Published:

Are Clinical Trials Available to the Older Patient Population?

Is there a cut-off age to clinical trial participation? Watch now to hear CLL expert Dr. Nicole Lamanna discuss the importance of elderly representation and eligibility to drive research forward.

Published:

Showing 9 of 391 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on October 19, 2015